Indications

Mikel Arteta improves at Klopp’s pace at Liverpool after unexpected indication of Arsenal performance – Bailey Keogh

Mikel Arteta has certainly had a performance roller coaster since joining Arsenal and it has been embodied this season. The Gunners started off terribly and found themselves at the bottom of the league, but after a good run of results the club are now two points away from second place. …

Read More »

Immunology Benchmarking Study Captures Key Increases in FTEs by Indication in Europe

READING, Pa., November 18, 2021 / PRNewswire / – PharmaForce International (PFI) recently completed a study comparing leading immunology sales and marketing organizations in France, Germany, Italy, Spain, and the UK. The report focuses on key companies promoting products in the fields of dermatology, rheumatology and gastroenterology throughout 2021. Since …

Read More »

High cholesterol: signs on your toes and fingers that the levels are dangerously high

Dr Rahul Agrawal stressed that “everyone needs to watch their cholesterol levels”. Although the disease is usually asymptomatic, one should be aware of “certain sets of physical symptoms”. The warning sign of high cholesterol can include sore fingers and toes. Such a sensation could be the direct result of a …

Read More »

Biosimilars Market by Product, Indication and Region

DUBLIN, November 10, 2021 / PRNewswire / – The “Global Biosimilars Market by Product (Monoclonal Antibodies (infliximab, Rituximab, Trastuzumab), Insulin, Interferon, Etanercept, Glucagon, Calcitonin), Indication (Oncology, Chronic Disease, Blood Disorder, Autoimmune Disease), Region – Forecast Until in 2026 “ report was added to ResearchAndMarkets.com offer. Research and Markets logo The …

Read More »

LianBio announces the price of its initial public offering

SHANGHAI, China and PRINCETON, NJ, October 31, 2021 (GLOBE NEWSWIRE) – LianBio, a biotechnology company dedicated to delivering innovative medicines to patients in China and other major Asian markets, today announced the award of its initial public offering of 20,312,500 US Depositary Shares (“ADS”) at a public offering price of …

Read More »

Wizards Hot Start Benchmarks and Indicators

The Wizards are 4-1 and are enjoying their best start in seven seasons. Important note: Every statistical data point should be viewed with a skeptical eye. Sample sizes are tiny and can fluctuate wildly as teams play more games. What we’re looking for now are pointers and benchmarks – guidance …

Read More »

Amazon has massive stake in Rivian, SEC says

Ecommerce powerhouse Amazon has disclosed a 20% stake in Rivian, an electric vehicle company in Normal, Ill., An SEC filing reveals. Amazon filed a Document 10-Q with the SEC earlier today, which summarized the company’s financial situation and data at the end of Q3 2021. In the filing, Amazon said …

Read More »

Patient-derived cancer model for plinabulin monotherapy supports treatment of SCLC

Preclinical data from patient-derived cancer models (PDX) presented at the AACR-NCI-EORTC 2021 International Virtual Conference on Molecular Targets and Cancer Therapeutics, held October 7-10, 2021, supports the use of plinabulin (formerly NPI-2358; Beyond Spring Pharmaceuticals), a vascular disrupting agent (VDA) against tubulin depolymerization with IC50 9.8 ~ 18 nM in …

Read More »

BMS buyout rumors drive Canadian Biopharma shares soar

Rumors of acquisition of major pharmaceutical company have pushed up Canadian stock prices Pharmaceutical Aurinia. Bristol Myers Squibb is reportedly courting biopharma to strike a buyout deal. Bristol Myers recently ran for Acceleron Pharma and its promising pulmonary arterial hypertension drug, but was beaten by Merck in an $ 11.5 …

Read More »

How temperature affects tire inflation

SIOUX FALLS, SD (KELO) – If you were to go anywhere today, you may have noticed that the tire pressure light came on this morning. There’s a good reason for this, and it doesn’t have to be an air leak. Reading your tire’s air pressure can be a good indication …

Read More »

OncoSec provides commercial update

Posted: October 20, 2021 at 3:02 p.m. CDT|Update: 13 minutes ago Pennington, New Jersey and SAN DIEGO, 20 October 2021 / PRNewswire / – OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a clinical-stage biotechnology company focused on the development of intratumoral cytokine-based immunotherapies to stimulate the body’s immune …

Read More »

Clinical challenges: when to add immunotherapy in breast cancer

For patients with breast cancer, current indications for immune checkpoint inhibitors (IBIs) are generally limited to triple negative breast cancer (TNBC), both in the early high-risk stages or in the advanced setting of tumors with certain levels of PD-L1 expression. However, researchers are seeking to broaden the indications, particularly in …

Read More »

CDE approved IND application to study the combination of APL-1202 from Asieris and Tislelizumab from BeiGene as a neoadjuvant therapy for patients with MIBC

Posted: October 13, 2021 at 3:47 a.m. EDT|Update: 2 hours ago SHANGHAI, October 13, 2021 / PRNewswire / – Asieris Pharmaceuticals (Asieris) today announced that the Center for Drug Evaluation (CDE) NMPA has approved the application of an investigational new drug (IND) of oral APL-1202 in combination with tislelizumab from …

Read More »

Intelligent Fire Emergency Lighting and Evacuation Indication System Market Size, Growth and Key Companies – TigerFire (Guangzhou) Lighting Technology, henZhen Hocen Emergency Lighting, GUANGDONG DP CO, Lose, ZFE, MPN, DP

New Jersey, United States, – A new Market Intelligence report published by Verified Market Reports, titled Intelligent Emergency Lighting and Fire Evacuation Indication Systems Market The 2021 Research Report provides a comprehensive analysis of the market with a forecast to 2028. Research analysts have produced this report using extensive primary …

Read More »

Isarna Therapeutics appoints Claus Schalper as CEO

MUNICH–(COMMERCIAL THREAD) –Isarna Therapeutics today announced the appointment of Claus Schalper as Chief Executive Officer. Mr. Schalper joins Isarna with over 20 years of experience as an executive and serial entrepreneur in the life science and biotechnology industries. Her appointment expands Isarna’s management team, which includes Professor Marion R. Munk …

Read More »

Maryland Revises Valuation Rules and Offers Alternative Methods of Determining Creditworthiness | Ballard Spahr srl

Maryland has enacted legislation that revises the rules for determining creditworthiness. On May 30, 2021, Maryland Governor Lawrence J. Hogan (R) signed HB1213 in the law, which adds to the Maryland Code Ann. Financial institutions (FI) § 1-212. As of October 1, 2021, certain financial institutions (banking institutions, credit unions, …

Read More »

Global $ 4.78 billion sleep apnea device (therapeutic v / s

Dublin, September 28, 2021 (GLOBE NEWSWIRE) – The “Global Sleep Apnea Devices Markets, Competition Forecast and Opportunities, 2026” report was added to ResearchAndMarkets.com offer. The global sleep apnea devices market was worth $ 4.78 billion in 2020 and is expected to grow at a rate of 8.79% through 2026 due …

Read More »

ReveraGen and Santhera Announce Funding for FDA Orphan Grant

Rockville, MichiganD, United States, and Pratteln, Switzerland, September 27, 2021 – ReveraGen Biopharma and Santhera Pharmaceuticals (SIX: SANN) announce that ReveraGen has received a USD 1.2 million FDA grant under its “Clinical Studies of Orphan Products in Unmet Rare Disease (R01)” grant program. The grant adds to existing grants from …

Read More »

SELLAS Life Sciences announces derivative settlement

NEW YORK, September 23, 2021 (GLOBE NEWSWIRE) – SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), an advanced-stage clinical biopharmaceutical company focused on the development of novel cancer immunotherapies for a wide range of indications, today announced that on September 10, 2021, the United States District Court …

Read More »

Wednesday September 22 (The Scenestar)

TO BUY TICKETS: John Legend with War and the Treaty at the Greek Theater The midweek point is here, Scenestar readers. It’s not exactly the weekend, but don’t let that stop you from enjoying the sounds of our Show of the Night selection: John legend! Her Bigger Love 2021 tour …

Read More »

Enlivex doses the first patient in phase IIb placebo-controlled

The first data from the multicenter randomized trial is expected in the second quarter of 2022 Nes-Ziona, Israel, September 22, 2021 (GLOBE NEWSWIRE) – Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company targeting diseased macrophages in patients with sepsis, COVID-19 and solid tumors, today announced …

Read More »

Global CBD Companion Animal Market Report 2021-2028 – Focus on CBD Products for General Health, Wellbeing, Anxiety & Stress – ResearchAndMarkets.com

DUBLIN – (COMMERCIAL THREAD)–The “Global CBD Pets Market Size, Share and Trend Analysis Report 2021-2028” report was added to ResearchAndMarkets.com offer. The global pet CBD market size is expected to reach USD 4.79 billion by 2028. It is expected to grow at a CAGR of 58.9% from 2021 to 2028. …

Read More »

Aadi Bioscience appoints Brendan Delaney as COO

LOS ANGELES, September 20, 2021 (GLOBE NEWSWIRE) – Aadi Bioscience, Inc (“Aadi”) (Nasdaq: AADI), a clinical-stage biopharmaceutical company specializing in precision therapies for genetically defined cancers with alterations in genes of the mTOR path, today announced the appointment of Brendan Delaney as Chief Operating Officer (COO). Brendan has had a …

Read More »

Daily Market Wire September 20, 2021

On Friday, most markets fell almost 1pc. French rapeseed continued to rise a bit. Chicago wheat December contract down 4.25 US cents / bu to 708.75 cents / bu; Kansas wheat contract in December drops 7.5c / bu to 713c / bu; Minneapolis December wheat down 6c / bu to …

Read More »

Shami: Strong indications that the occupation of Afrin has turned into a safe haven for extremists – ANHA | HAWARNEWS

The Syrian Democratic Forces media center issued a press release from the center’s director, Farhad Shami, in which he said: Numerous reports received in recent weeks concerning the movements of the organization (Hay’at Tahrir al-Sham) in the occupied area of ​​Afrin, have confirmed that the leaders of the organization have …

Read More »

Hasan Bashir expects Sudanese economy to improve next year

The Sudanese economy will improve in 2022 provided the political and security situation remains stable, according to economic expert Hasan Bashir. In an interview with Radio Dabanga, Dr Hasan Bashir, professor of economics at El Nilein University in Khartoum, spoke of the expected loans, grants and investments that will help …

Read More »

Atopic Keratoconjunctivitis (Ophthalmology) 2021 Drug Development Research Report – ResearchAndMarkets.com |

DUBLIN – (BUSINESS WIRE) – August 9, 2021– the “Atopic keratoconjunctivitis (ophthalmology) – Drugs in development, 2021” report was added to ResearchAndMarkets.comoffer. Atopic Keratoconjunctivitis (Ophthalmology) – Drugs in Development, 2021 provides an overview of the atopic keratoconjunctivitis pipeline landscape. The report provides comprehensive information on treatments under development for atopic …

Read More »

What are the first signs of infertility?

Infertility means the inability of a couple to conceive naturally, even after one year of unprotected sexual cohabitation. It affects many couples around the world, but there are treatment options as well. According to Dr Sudip Basu, gynecologist and infertility expert at Srishti Infertility Clinic, Kolkata, the causes of infertility …

Read More »

Humira, Keytruda, Opdivo, Avastin, Rituxan, Stelara, Herceptin, Enbrel

DUBLIN, August 3, 2021 / PRNewswire / – The Top-selling biologics market, 2021-2030: focus on product landscape assessment, ongoing clinical trials, analysis of promotional content, alternative lifecycle management strategies, biosimilar competition, cost comparison annual salaries, sales trends and future opportunities ” report was added to ResearchAndMarkets.com offer. The report “Top …

Read More »

Tuttosport: Pioli channels Mancini’s Italy in 6-0 win

AC Milan kicked off their pre-summer 2021 campaign in an ideal fashion by beating Serie C side Pro Sesto 6-0 at Milanello. This morning’s edition of Tuttosport (via Milanlive) looked at some of the tactical cues we saw yesterday from head coach Stefano Pioli, who theoretically featured the starting XI …

Read More »

Roxadustat AdComm decision tops the week

“While we are disappointed with today’s outcome, we believe the scientific evidence supports the approval of roxadustat in the United States and will work with the FDA as it completes its review of the new drug application for the roxadustat, ”said Enrique Conterno, Managing Director of FibroGen. in a report. …

Read More »

Ascletis announces the assay of the first cohort of healthy subjects in the FXR Agonist ASC42 transition study for the indication of chronic hepatitis B in China

–This bridging study to select doses for the phase II trial in China in patients with chronic hepatitis B (CHB) – ASC42 clinical trials are ongoing in the United States and China for non-alcoholic steatohepatitis (NASH) and CHB. HANGZHOU and SHAOXING, China, July 12, 2021 / PRNewswire / – Ascletis, …

Read More »

UFP Technologies share gives E

The share of UFP Technologies (NAS: UFPT, 30 years Financials) is considered to be significantly overvalued, according to the calculation of GuruFocus Value. The GuruFocus Value is GuruFocus’s estimate of the fair value at which the stock is to trade. It is calculated based on the historical multiples at which …

Read More »

Locanabio takes over the ex-CRISPR Tx, Sanofi at the head of the scientific director of Sanofi, hangs the CMO of Audentes

Locanabio doubled its C-suite hires on Tuesday, seizing talent from CRISPR Therapeutics and Astellas Audentes Therapeutics to lead its preclinical pipeline into the future. John Leonard, Ph.D., who was responsible for hematology and in vivo research at CRISPR Therapeutics, joins as Scientific Director. Edward Conner, MD, who was Chief Medical …

Read More »

Elicio Therapeutics announces the launch of its phase 1/2 dose escalation study of ELI-002 (AMPLIFY-201) in KRAS-induced cancers

The study will assess the safety and preliminary efficacy of ELI-002, an investigational therapeutic vaccine targeting lymph nodes in patients with KRAS-induced tumors and minimal residual disease after surgical resection The study will assess circulating tumor DNA (ctDNA) to obtain a preliminary indication of anti-tumor activity The study is expected …

Read More »

Pediatric indications, more in the Alzheimer’s pipeline?

The PDUFA date passes without any action on Rinvoq. the The FDA does adhere to the action dates of the Prescription Drug User Fees Act (PDUFA) for Supplementary New Drug Requests (sNDA) for Rinvoq (upadacitinib) for the treatment of adults with active psoriatic arthritis and adults with active ankylosing spondylitis. …

Read More »

Family characteristics: dispel the fog

What you might not know about your eyes MISSION, KS / ACCESSWIRE / June 25, 2021 / If you are over 40, you may have noticed that your vision is getting worse – maybe you need a light to read, or you have trouble driving at night. What is often …

Read More »

July 4 trips expected to reach pre-pandemic levels

BUFFALO, NY (WKBW) – Independence Day weekend could be the first public holiday in more than a year to see pre-pandemic travel levels. “All indications now point to a busy Independence Day.” Paula Twidale, Senior Vice President, AAA Travel According to AAA, more than 47.7 million Americans are expected to …

Read More »

Cannabics Pharmaceuticals to Launch Drug Development Programs for Prostate Cancer and Neurodegenerative and Mental Health Diseases

TEL AVIV, Israel and BETHESDA, Maryland, June 17, 2021 / PRNewswire / – Cannabics Pharmaceuticals (OTCQB: CNBX), a global leader in the development of cancer-related cannabinoid drugs, today announced the expansion of its research program with new drug development projects targeting prostate cancer, neurodegenerative diseases and mental health. The announcement …

Read More »

Neo Medical obtains both FDA approval and CE mark

LAUSANNE, Switzerland, June 16, 2021 / PRNewswire / – Neo Medical, a Switzerland-based medical technology company developing value-based care solutions for functional fusion in spine surgery, today announced two major regulatory milestones for European markets and American. First, Neo Medical received 510 (k) clearance from the FDA for the use …

Read More »

AVITA Medical announces preliminary fourth quarter 2021

VALENCIA, California and MELBOURNE, Australia, June 15, 2021 (GLOBE NEWSWIRE) – AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that develops and markets a technology platform that enables the restoration of autologous skin care for multiple unmet needs, today announced unaudited preliminary financial results for fiscal fourth …

Read More »

US FDA approved IND application to study combination of APL-1202 from Asieris and Tislelizumab from BeiGene as a neoadjuvant therapy for patients with MIBC

SHANGHAI, June 14, 2021 / PRNewswire / – Asieris Pharmaceuticals (Asieris) today announced that the United States Food and Drug Administration (FDA) has approved the application of a new investigational drug (IND) of APL-1202 via the orally in combination with BeiGene’s tislelizumab as a neoadjuvant therapy in patients with bladder …

Read More »

HMG / Courtland Property Stock – GuruFocus.com

HMG / Courtland Properties (AMEX: HMG, 30-year Financials) stock is considered slightly undervalued, according to the GuruFocus value calculation. The GuruFocus Value is GuruFocus’s estimate of the fair value at which the stock is to trade. It is calculated based on the historical multiples at which the stock has traded, …

Read More »

Summary of FDA approvals: Aduhelm, Brexafemme, Tembexa

A weekly update on new drug approvals and indications from the United States Food and Drug Administration (FDA). New approvals Aduhelm approved for slowing Alzheimer’s disease by targeting motor disease process Aduhelm (aducanumab) by Biogen received acceleration approval for the treatment of patients with Alzheimer’s disease, making it the first …

Read More »